Latest Articles
YC’s Fall 2025 Startup Requests: What They Signal for Women’s Health Innovation - Femtech Insider
YC’s Fall 2025 Startup Requests: What They Signal for Women’s Health Innovation Femtech Insider
Published: Aug. 6, 2025, 8:31 a.m.
Figure 3. Mechanisms of action of related EMT and MMPs in EMS, OC, BC,... - researchgate.net
Figure 3. Mechanisms of action of related EMT and MMPs in EMS, OC, BC,... researchgate.net
Published: July 31, 2025, 9:34 p.m.
What’s New in Femtech This Week? (July 31, 2025) - Femtech Insider
What’s New in Femtech This Week? (July 31, 2025) Femtech Insider
Published: July 31, 2025, 7:59 a.m.
Penn State Researchers Develop 10-Minute At-Home Endometriosis Test Using Menstrual Blood - Femtech Insider
Penn State Researchers Develop 10-Minute At-Home Endometriosis Test Using Menstrual Blood Femtech Insider
Published: July 28, 2025, 6:20 a.m.
What’s New in Femtech This Week? (July 24, 2025) - Femtech Insider
What’s New in Femtech This Week? (July 24, 2025) Femtech Insider
Published: July 25, 2025, 7:59 a.m.
Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M - Femtech Insider
Gesynta Pharma Adds $3.9M in Series B Funding for Endometriosis Drug, Total Round Reaches $31.5M Femtech Insider
Published: July 23, 2025, 5:39 a.m.
Gesynta Pharma Raises Additional $3.9M in Series B Second Closing, Total Round Reaches $31.5M - Femtech Insider
Gesynta Pharma Raises Additional $3.9M in Series B Second Closing, Total Round Reaches $31.5M Femtech Insider
Published: July 23, 2025, 5:34 a.m.
UK femtech startup Daye secures patent for its organic plastic-free diagnostic & menstrual tampons - Silicon Canals
UK femtech startup Daye secures patent for its organic plastic-free diagnostic & menstrual tampons Silicon Canals
Published: July 22, 2025, 1:58 p.m.
XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... - researchgate.net
XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... researchgate.net
Published: July 9, 2025, 7:31 p.m.
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Link copied to clipboard!